TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11707638

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg/day)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: CET/CST
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control treatment (education and relaxation)
Number of subjects: 165
Study: 9141923

Group type: EXPERIMENTAL
Intervention: ORG 9487 (1.5-2.0 mg/kg)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: ORG 9487 (up to 2.0 mg/kg for adults, up to 1.5 mg/kg for elderly)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181
Study: 7702805

Group type: EXPERIMENTAL
Intervention: High sodium diet (200 mmol)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Low sodium diet (20 mmol)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Low sodium diet (20 mmol) with insulin dose of 0.8 mU/min
Number of subjects: 14
Study: 3124676

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 10 micrograms.kg-1.h-1 naloxone after a 400 micrograms bolus (group F + N)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 5% dextrose (group F)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both groups (F + N and F)
Number of subjects: 16
Study: 29993687

Group type: EXPERIMENTAL
Intervention: 3D deep learning network with randomized connection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Convolutional LSTM and 3D convolution
Number of subjects: 0
Study: 26930191

Group type: EXPERIMENTAL
Intervention: ADOC group (occupation-based goal setting using the ADOC)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (impairment-based approach without goal setting tools)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: ADOC group
Number of subjects: 44
Study: 24529119

Group type: EXPERIMENTAL
Intervention: Reduced salt diet (6 g/day)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Usual salt diet (9 g/day)
Number of subjects: 25
Study: 22527555

Group type: EXPERIMENTAL
Intervention: Modified procedure (group B)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Traditional technique (group A)
Number of subjects: 72
Study: 20676333

Group type: EXPERIMENTAL
Intervention: HPV-16/18 AS04-adjuvanted vaccine
Number of subjects: 321

Group type: COMPARATOR
Intervention: Hepatitis A vaccine
Number of subjects: 321
Study: 17414241

Group type: EXPERIMENTAL
Intervention: IM aripiprazole 9.75 mg
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: IM aripiprazole 15 mg
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: IM lorazepam 2 mg
Number of subjects: 301

Group type: COMPARATOR
Intervention: IM placebo
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: All active treatments (IM aripiprazole 9.75 mg, 15 mg, IM lorazepam)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: IM lorazepam
Number of subjects: 301
Study: 16305857

Group type: EXPERIMENTAL
Intervention: Off-pump surgery
Number of subjects: 120

Group type: COMPARATOR
Intervention: On-pump surgery
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Normal preoperative radiologic findings
Number of subjects: 120
Study: 11955846

Group type: EXPERIMENTAL
Intervention: Gamma intracoronary radiation therapy (ICRT)
Number of subjects: 416

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 416
Study: 7883849

Group type: EXPERIMENTAL
Intervention: Estrogen and progestin replacement (n = 22)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No replacement (control group, n = 26)
Number of subjects: 48
Study: 2649413

Group type: EXPERIMENTAL
Intervention: 40 mg of hyoscine intravenously before acid infusion
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control group (no hyoscine)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Non-symptomatic patients (no treatment)
Number of subjects: 143
Study: 861131

Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Labetalol (400 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31525451

Group type: EXPERIMENTAL
Intervention: Mechanical debridement with adjunct antimicrobial photodynamic therapy (MD + aPDT)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Mechanical debridement alone (MD)
Number of subjects: 98
Study: 27597661

Group type: EXPERIMENTAL
Intervention: TRUCLEAR INCISOR Plus (TIP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MyoSure Classic (MC)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MyoSure Lite (ML)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TRUCLEAR ULTRA Plus (TUP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: MyoSure XL (MXL)
Number of subjects: 60
Study: 27782964

Group type: EXPERIMENTAL
Intervention: Immediate initiation of antiretroviral therapy (ART)
Number of subjects: 4685

Group type: COMPARATOR
Intervention: Deferred initiation of antiretroviral therapy (ART)
Number of subjects: 4685
Study: 23298345

Group type: EXPERIMENTAL
Intervention: Ovariectomy (n = 8)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Salpingectomy (n = 8)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Salpingectomy
Number of subjects: 16
Study: 21991735

Group type: EXPERIMENTAL
Intervention: Ondansetron (4 mg)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Meperidine (0.4 mg/kg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (2 cc normal saline)
Number of subjects: 90
Study: 19651824

Group type: EXPERIMENTAL
Intervention: Autologous chondrocyte implantation
Number of subjects: 0
Study: 17299471

Group type: EXPERIMENTAL
Intervention: Oral methionine (0.17 mmol/kg body weight) with oral iron (ferrous sulfate, 13 mumol/kg)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Oral methionine (0.17 mmol/kg body weight) without oral iron
Number of subjects: 5
Study: 15314347

Group type: EXPERIMENTAL
Intervention: Oral health education program (daily for 20 minutes for four weeks)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no oral health education)
Number of subjects: 67
Study: 11607883

Group type: EXPERIMENTAL
Intervention: SRL treatment before surgery (30 mg every 14 days for 3 months, then every 10 days until 6 months)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Surgery after SRL treatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SRL treatment (30 mg every 14 days for 3 months, then every 10 days until 6 months)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Surgery followed by SRL
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SRL treatment before surgery
Number of subjects: 20
Study: 9796594

Group type: EXPERIMENTAL
Intervention: Massage therapy (20 minutes daily for 1 month)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard topical care only (Control)
Number of subjects: 0
Study: 8035026

Group type: EXPERIMENTAL
Intervention: SPf66 malaria vaccine (three doses on days 0, 20, and 112)
Number of subjects: 2360
Study: 2493239

Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 3137

Group type: EXPERIMENTAL
Intervention: Cefotaxime
Number of subjects: 3137

Group type: COMPARATOR
Intervention: Nontreatment (control)
Number of subjects: 3137
Study: 30383163

Group type: EXPERIMENTAL
Intervention: Hearing aid fitting methods (NAL‐NL2 and Audiogram+) with broadband loudness balancing
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Hearing aid fitting methods (NAL‐NL2 and Audiogram+) with narrowband loudness balancing
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 14
Study: 28741385

Group type: EXPERIMENTAL
Intervention: Teneligliptin 20 mg
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Teneligliptin
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo/teneligliptin
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Teneligliptin/teneligliptin
Number of subjects: 148
Study: 24395557

Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate 1500 mg
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate 800 mg
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Glucosamine and chondroitin combination
Number of subjects: 605

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 605
Study: 23088186

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser (λ=2.78 μm, 20 Hz, pulse duration approximately 140 μs, noncontact mode using a 600‐μm tip) at various power outputs (1.0 W to 4.0 W)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group using conventional technique with burs (G1)
Number of subjects: 140
Study: 21654609

Group type: EXPERIMENTAL
Intervention: Vitex agnus castus (VAC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 0
Study: 18614225

Group type: EXPERIMENTAL
Intervention: Horizontal increments (three layers)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Oblique increments (three layers)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Oblique increments (four layers)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Single Bond adhesive
Number of subjects: 4
Study: 16490911

Group type: EXPERIMENTAL
Intervention: Checklist of 53 common side effects
Number of subjects: 214

Group type: COMPARATOR
Intervention: Open-ended question
Number of subjects: 214

Group type: COMPARATOR
Intervention: Open-ended, defined question
Number of subjects: 214
Study: 15491533

Group type: COMPARATOR
Intervention: Primary health care
Number of subjects: 560

Group type: COMPARATOR
Intervention: Pneumology practices
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Overall factors related to HRQL
Number of subjects: 560
Study: 11079237

Group type: EXPERIMENTAL
Intervention: Cognitive stimulation through idea exposure via audiotape during brainstorming (Experiments 1 and 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive stimulation through electronic brainstorming (Experiment 3)
Number of subjects: 0
Study: 9286597

Group type: EXPERIMENTAL
Intervention: Glucose ingestion (GLU) - 500 ml of glucose polymer solution containing 25 g glucose 15 min before exercise
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (CON) - sweet placebo (aspartame)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Both GLU and CON
Number of subjects: 7
Study: 7811540

Group type: EXPERIMENTAL
Intervention: Switching to didanosine after prior zidovudine therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High dosages of nevirapine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-level resistance to zidovudine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acquisition of an HIV strain with high-level resistance to zidovudine
Number of subjects: 0
Study: 3217412

Group type: EXPERIMENTAL
Intervention: Caffeine 4 mg/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Caffeine 8 mg/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Triazolam
Number of subjects: 12

Group type: COMPARATOR
Intervention: Caffeine placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: Triazolam placebo
Number of subjects: 12
Study: 28882072

Group type: EXPERIMENTAL
Intervention: Exercise intervention for postnatal depression
Number of subjects: 0
Study: 30343063

Group type: EXPERIMENTAL
Intervention: Bracket debonding with bur roughening
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Bracket debonding with sandblasting
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Polishing after bracket debonding
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no bracket debonding)
Number of subjects: 70
Study: 28746183

Group type: EXPERIMENTAL
Intervention: Modified SMILE procedure (liquid infiltration group)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Traditional SMILE (control group)
Number of subjects: 52
Study: 26232692

Group type: EXPERIMENTAL
Intervention: Diclofenac suppository 2 hours before biopsy + 10 mL of 2% Xylocaine gel 5 minutes before biopsy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Xylocaine gel only
Number of subjects: 100
Study: 23116363

Group type: EXPERIMENTAL
Intervention: SCH 900435 8 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SCH 900435 12 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SCH 900435 20 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SCH 900435 30 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visual effects study
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple ascending dose study
Number of subjects: 0
Study: 20718311

Group type: EXPERIMENTAL
Intervention: Community-oriented primary health care (CPHC) intervention including fluoride varnish applications, training of primary care workers, and health promotion for oral health at individual, family, and community levels with six-monthly visits over two years.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control communities received no intervention, only baseline and two-year follow-up visits.
Number of subjects: 30
Study: 18236934

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 17154730

Group type: EXPERIMENTAL
Intervention: Video-feedback Intervention to promote Positive Parenting and Sensitive Discipline (VIPP-SD)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 237
Study: 14743096

Group type: EXPERIMENTAL
Intervention: Invasive conventional weaning (group A)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Extubation relayed by nasal oxygen therapy (group B)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Extubation relayed by non-invasive ventilation (NIV) (group C)
Number of subjects: 208
Study: 11110676

Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Autologous transplantation (ABMT)
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Allogeneic bone marrow transplantation (alloBMT)
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Cytogenetic risk status
Number of subjects: 609
Study: 9178382

Group type: EXPERIMENTAL
Intervention: Short version of CPR checklist
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Longer detailed CPR checklist
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 169
Study: 8252948

Group type: EXPERIMENTAL
Intervention: Blood-conserving arterial line system
Number of subjects: 31

Group type: COMPARATOR
Intervention: Conventional arterial line system
Number of subjects: 31
Study: 3531112

Group type: EXPERIMENTAL
Intervention: Radiotherapy in hyperbaric oxygen (HBO)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Radiotherapy in air
Number of subjects: 104
Study: 29424957

Group type: EXPERIMENTAL
Intervention: High-fat diet
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: Pooled results from both trials
Number of subjects: 1002
Study: 27559057

Group type: EXPERIMENTAL
Intervention: Routine duplex ultrasound surveillance (performed 2, 4, and 8 weeks postoperatively)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Selective duplex ultrasound (performed only when physical examination detected an abnormality)
Number of subjects: 150
Study: 24825641

Group type: EXPERIMENTAL
Intervention: PET-CT
Number of subjects: 263

Group type: COMPARATOR
Intervention: Control (no PET-CT)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Standardized uptake value
Number of subjects: 263
Study: 23279632

Group type: EXPERIMENTAL
Intervention: ezetimibe/simvastatin 10/20 mg
Number of subjects: 808

Group type: COMPARATOR
Intervention: doubling baseline statin (simvastatin 40 mg or atorvastatin 20 mg)
Number of subjects: 808

Group type: COMPARATOR
Intervention: rosuvastatin 10 mg
Number of subjects: 808
Study: 21930544

Group type: EXPERIMENTAL
Intervention: N-O-T+FIT (Not on Tobacco plus physical activity module)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: N-O-T (Not on Tobacco)
Number of subjects: 233

Group type: COMPARATOR
Intervention: BI (Brief Intervention)
Number of subjects: 233
Study: 19146131

Group type: EXPERIMENTAL
Intervention: Single Bond (SB)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Vitremer (V)
Number of subjects: 80

Group type: COMPARATOR
Intervention: FluroShield (F)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Helioseal Clear Chroma (H)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Fuji IX (FIX)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Clearfil Protect Bond (CF)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Fuji II‐LC (FII)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ketac‐Molar (KM)
Number of subjects: 80
Study: 16357545

Group type: EXPERIMENTAL
Intervention: Breathing intolerance index for ventilator users (n=11)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Breathing intolerance index for nonventilator users (n=31)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Breathing intolerance index for healthy controls (n=25)
Number of subjects: 42
Study: 12803266

Group type: EXPERIMENTAL
Intervention: Endotracheal tube advanced into the right main bronchus
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard tracheal intubation with a second endotracheal tube placed in the oesophagus
Number of subjects: 42
Study: 10768799

Group type: EXPERIMENTAL
Intervention: High 5 school-based nutrition intervention
Number of subjects: 28
Study: 8656254

Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m2
Number of subjects: 471

Group type: COMPARATOR
Intervention: Paclitaxel 135 mg/m2
Number of subjects: 471
Study: 1613206

Group type: EXPERIMENTAL
Intervention: Heated humidifier (HH) (Draegger Aquaport)
Number of subjects: 116
Study: 6433769

Group type: EXPERIMENTAL
Intervention: HB 420 (3.5 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: HB 419 (5 mg)
Number of subjects: 8
Study: 30923521

Group type: EXPERIMENTAL
Intervention: Ty21a vaccination
Number of subjects: 0
Study: 30067074

Group type: EXPERIMENTAL
Intervention: GS100 (nonsystemic, orally administered hydrogel) co-administered with metformin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: GS100 co-administered with metformin
Number of subjects: 24
Study: 27026335

Group type: EXPERIMENTAL
Intervention: Raloxifene treatment
Number of subjects: 50

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 50
Study: 25127988

Group type: EXPERIMENTAL
Intervention: Abnormal CA-125 levels
Number of subjects: 38818

Group type: COMPARATOR
Intervention: Normal CA-125 levels
Number of subjects: 38818
Study: 22975086

Group type: EXPERIMENTAL
Intervention: Nutrition education intervention (90-minute class with a registered dietitian/certified diabetes educator and twice keeping 3-day food records)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Nutrition education intervention
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 66
Study: 20074843

Group type: EXPERIMENTAL
Intervention: Distribution of BLS/AED manuals prior to the course (Group A)
Number of subjects: 303

Group type: COMPARATOR
Intervention: No distribution of BLS/AED manuals prior to the course (Group B)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 303
Study: 17522248

Group type: EXPERIMENTAL
Intervention: RC-1291, 50 mg qd for 6 days
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: RC-1291, 75 mg qd for 6 days
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 16873952

Group type: EXPERIMENTAL
Intervention: CoQ(10) supplementation (Q-Gel 120 mg) + 400 mg alpha-tocopherol + 250 mg vitamin C a day
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard antiasthmatic therapy
Number of subjects: 41
Study: 11904108

Group type: EXPERIMENTAL
Intervention: Thyroxine treatment (50 to 100 microg daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Thyroxine treatment
Number of subjects: 40
Study: 10453443

Group type: EXPERIMENTAL
Intervention: Selected vegetables (SV) added to the daily diet of stage III and IV NSCLC patients (SVG group).
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (CG) without selected vegetables (SV).
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Toxicity study group (TG) with selected vegetables (SV).
Number of subjects: 24
Study: 7603598

Group type: EXPERIMENTAL
Intervention: Colour Doppler studies
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard duplex sonography
Number of subjects: 64

Group type: COMPARATOR
Intervention: Angiography
Number of subjects: 64
Study: 2083404

Group type: EXPERIMENTAL
Intervention: Choline magnesium trisalicylate (CMT, trilisate) pre-treatment at a dose of 3000 mg daily for 3 days
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Choline magnesium trisalicylate (CMT, trilisate) pre-treatment
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 7459899

Group type: EXPERIMENTAL
Intervention: High-dose cyclophosphamide (CTX)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Cyclophosphamide, methotrexate, 5-FU, and hydroxyurea (CMFH)
Number of subjects: 58
Study: 31605663

Group type: EXPERIMENTAL
Intervention: Exercise training (3 months of supervised aerobic and resistance exercise training, twice a week for 60 min)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Exercise training (after withdrawal of supervised exercise)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 50
Study: 31845228

Group type: EXPERIMENTAL
Intervention: Shenqi Fuzheng Injection (SFI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cranial radiation alone (Control)
Number of subjects: 0
Study: 28194877

Group type: EXPERIMENTAL
Intervention: Focused breastfeeding counselling (intervention group)
Number of subjects: 3541

Group type: COMPARATOR
Intervention: Usual care (reference group)
Number of subjects: 3541
Study: 25820625

Group type: EXPERIMENTAL
Intervention: Circular-stapled anastomosis (CSA)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Hand-sutured anastomosis (HSA)
Number of subjects: 238
Study: 23467957

Group type: EXPERIMENTAL
Intervention: Bovine pericardial matrix (BPM)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Superficial musculoaponeurotic system (SMAS) flap
Number of subjects: 40
Study: 21093066

Group type: EXPERIMENTAL
Intervention: 75% silver nitrate cauterization
Number of subjects: 101

Group type: COMPARATOR
Intervention: 95% silver nitrate cauterization
Number of subjects: 101
Study: 19682490

Group type: EXPERIMENTAL
Intervention: Computer-delivered intervention program for mother-daughter dyads
Number of subjects: 916

Group type: COMPARATOR
Intervention: Control group (test-only)
Number of subjects: 916